These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13627751)

  • 1. Summary of results obtained with CB 1348.
    GUMPORT SL; GOLOMB FM; WRIGHT JC
    Ann N Y Acad Sci; 1958 Apr; 68(3):1024-34. PubMed ID: 13627751
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of malignant lymphoma with chlorambucil (CB 1348, leukeran).
    DE VRIES SI
    Acta Haematol; 1958 Jan; 19(1):1-8. PubMed ID: 13508018
    [No Abstract]   [Full Text] [Related]  

  • 3. P-(Di-2-chloroethyl) aminophenylbutyric acid (CB 1348) in the treatment of cancer.
    OLSON KB
    Ann N Y Acad Sci; 1958 Apr; 68(3):1017. PubMed ID: 13627749
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of CB 1348 in malignant lymphoma and related diseases.
    ISRAELS LG; GALTON DA; TILL M; WILTSHAW E
    Ann N Y Acad Sci; 1958 Apr; 68(3):915-25. PubMed ID: 13627740
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of CB 1348 in leukemias and lymphomas.
    DOAN CA; WISEMAN BK; BOURONCLE BA
    Ann N Y Acad Sci; 1958 Apr; 68(3):979-95. PubMed ID: 13627745
    [No Abstract]   [Full Text] [Related]  

  • 6. [Observations on the application of CB-1348 in lymphatic leukemias].
    LAWKOWICZ W; BECALSKI J
    Pol Arch Med Wewn; 1959; 29(3):420-2. PubMed ID: 13667708
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of malignant systemic affections of the lymphatic tissue with CB 1348].
    DE VRIES SI
    Ned Tijdschr Geneeskd; 1956 Jul; 100(29):2046-53. PubMed ID: 13369613
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials of p-(di-2-chloroethylamino)-phenylbutyric acid (CB 1348) in malignant lymphoma.
    GALTON DA; ISRAELS LG; NABARRO JD; TILL M
    Br Med J; 1955 Nov; 2(4949):1172-6. PubMed ID: 13269823
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic results in treatment of Hodgkin's disease with CB 1348 and R-48.
    ROTTINO A
    Blood; 1957 Aug; 12(8):755-65. PubMed ID: 13446003
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of CB 1348 in Hodgkin's disease and allied disorders.
    BOURONCLE BA; DOAN CA; WISEMAN BK; FRAJOLA WJ
    AMA Arch Intern Med; 1956 Jun; 97(6):703-14. PubMed ID: 13312712
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with CB 1348 (NN-di(2-chloroethyl, -P-aminophenylbutyric acid) in the treatment of chronic lymphatic leukaemia.
    HANSEN PB
    Acta radiol; 1957 Mar; 47(3):210-16. PubMed ID: 13424344
    [No Abstract]   [Full Text] [Related]  

  • 12. Chlorambucil and triethylene thiophosphoramide in the treatment of neoplastic disease.
    ULTMANN JE; HYMAN GA; GELLHORN A
    Ann N Y Acad Sci; 1958 Apr; 68(3):1007-16. PubMed ID: 13627748
    [No Abstract]   [Full Text] [Related]  

  • 13. Hematological changes following treatment with p-(di-2-chlorethylamino)-phenylbutyric acid (CB 1348) in cancer. I. Effect on lymphocytes and platelets.
    PILLERS EK; MAGALINI SI
    Cancer; 1958; 11(2):410-5. PubMed ID: 13511361
    [No Abstract]   [Full Text] [Related]  

  • 14. Remissions induced by chlorambucil in chronic granulocytic leukemia.
    KRAKOFF IH; KARNOFSKY DA; BURCHENAL JH
    J Am Med Assoc; 1958 Feb; 166(6):629-31. PubMed ID: 13502041
    [No Abstract]   [Full Text] [Related]  

  • 15. Early experience with p-(N, N-di-2-chloroethyl)-aminophenylbutyric acid (CB 1348), a new chemotherapeutic agent effective in the treatment of chronic lymphocytic leukemia.
    ALTMAN SJ; HAUT A; CARTWRIGHT GE; WINTROBE MM
    Cancer; 1956; 9(3):512-7. PubMed ID: 13330000
    [No Abstract]   [Full Text] [Related]  

  • 16. Chlorambucil in treatment of chronic lymphocytic leukemia and certain lymphomas.
    GELLHORN A; HYMAN GA; ULTMANN JE
    J Am Med Assoc; 1956 Sep; 162(3):178-83. PubMed ID: 13357311
    [No Abstract]   [Full Text] [Related]  

  • 17. Hematological changes following treatment with p-(di-2-chlorethylamino)-phenylbutyric acid (CB 1348) in cancer. II. Effect on erythroid and myeloid cells in blood and bone marrow.
    MAGALINI SI; PILLERS EK
    Cancer; 1958; 11(2):416-20. PubMed ID: 13511362
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of CB-1348 (chlorambucil, leukeran) and CB-1364.
    RUNDLES W; GRIZZLE J; BONO VH; JONSSON U; HUGULEY CM; CORLEY CC
    Cancer Chemother Rep; 1962 Feb; 16():223-30. PubMed ID: 14495284
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of chlorambucil (CB 1348) on growth and metabolism.
    YOUNG RS; HURWITZ L; GOLDENTHAL EI
    J Cell Comp Physiol; 1958 Dec; 52(3):353-60. PubMed ID: 13654459
    [No Abstract]   [Full Text] [Related]  

  • 20. CB 1348 therapy in leukemia and allied diseases.
    SAMPEY JR
    Am Pract Dig Treat; 1959 Aug; 10():1361-4. PubMed ID: 14441245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.